Journal Club 2023-2024 Year to Date Articles |
July 25, 2023: Koneru, Taye |
Triple–Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial (SK) |
A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis (TT) |
August 8, 2023: Estes, Shah |
Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH (WE) |
Intravascular Imaging-Guided or Angio-Guide Complex PCI (ZS) |
August 18, 2023: Singh, Rahesh |
Time-Restricted Eating Without Calorie Counting for Weight Loss in a Racially Diverse Population (AS) |
Health Consequences of Thymus Removal in Adults (JR) |
August 22, 2023: Zhao, Eldridge |
Perioperative Pembrolizumab for Early Stage Non-Small-Cell Lung Cancer (LZ) |
Cardiovascular Safety of Testosterone-Replacement Therapy (CE) |
September 5, 2023: Hulgan, D'Cunha |
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection (DH) |
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma (PD) |
September 19, 2023: Estes, Fan |
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts (WE) |
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer (EF) |
October 3, 2023: Tabba, Shah |
Platelet Transfusion before CVC Placement in Patients with Thrombocytopenia (ST) |
Complete or Culprit-Only PCI in Older Patients with Myocardial Infarction (ZS) |
October 17, 2023: Sivakumar, Lujan |
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity (SK) |
Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation (SL) |
October 20, 2023: Hsu, Kondle |
Ceftobiprole for Treatment of Complicated Staphylococcus aureus Bacteremia (SH) |
Eplontersen for Hereditary Transthyretin Amyloidosis with Polyneuropathy (SK) |
November 21, 2023: Khan, D'Cunha |
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer (HK) |
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer (PD) |
Decemeber 7, 2023: Fan, Momin |
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation (EF) |
Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia (AM) |
January 2, 2024: Weinstein, Plumber |
Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia (KW) |
A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina (AP) |
January 18, 2024: Shah, Hulgan |
Drug-Eluting Resorbable Scaffold versus Angioplasty for Infrapopliteal Artery Disease (ZS) |
Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy (DH) |
January 30, 2024: Koneru, Estes |
Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper (SCK) |
Cumulative Incidence of Thiazide-Induced Hyponatremia: A Population-Based Cohort Study (WE) |
February 13, 2024: Kondle, Plumber |
Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection (SK) |
Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults (AP) |
February 27, 2024: Thiruma, Lue |
Cefepime–Taniborbactam in Complicated Urinary Tract Infection (JT) |
RNA Interference With Zilebesiran for Mild to Moderate Hypertension: The KARDIA-1 Randomized Clinical Trial (BL) |
March 4, 2024: Sudheer, Hsu |
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis (NS) |
Rusfertide, a Hepcidin Mimetic, for Control of Erythrocytosis in Polycythemia Vera (SH) |
March 12, 2024: Hoang, Taye |
Omalizumab for the Treatment of Multiple Food Allergies (BH) |
Mortality and Morbidity Among Individuals With Hypertension Receiving a Diuretic, ACE Inhibitor, or Calcium Channel Blocker A Secondary Analysis of a Randomized Clinical Trial (TT) |
April 9, 2024: Lujan, Sudheer |
Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria (SL) |
Single-Dose Psilocybin Treatment for Major Depressive Disorder A Randomized Clinical Trial (NS) |
May 7, 2024: Khan, Eldridge |
Exagamglogene Autotemcel for Severe Sickle Cell Disease (HK) |
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction (CE) |
May 13, 2024: Zhao, Lue |
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma (LZ) |
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction (BL) |
May 21, 2024: Weinstein, Thiruma |
Trial of Thrombectomy for Stroke with a Large Infarct of Unrestricted Size (KW) |
Transcatheter or Surgical Treatment of Aortic-Valve Stenosis (JT) |
June 4, 2024: Sivakumar, Hoang |
Andexanet for Factor Xa Inhibitor–Associated Acute Intracerebral Hemorrhage (RS) |
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy (BH) |